Last reviewed · How we verify
NCT05290675
Quantra QPlus Sample Type Comparison
trial testing Quantra QPlus System in Coagulation Defect; Bleeding in 50 participants. Completed in 2 November 2022.
31 August 2022
Quick facts
| Lead sponsor | HemoSonics LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 4 November 2021 |
| Primary completion | 31 August 2022 |
| Estimated completion | 2 November 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Quantra QPlus System
Conditions studied
- Coagulation Defect; Bleeding — all drugs for Coagulation Defect; Bleeding →
Sponsor
HemoSonics LLC — full company profile →
Who can join
18 and older, any sex, with Coagulation Defect; Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single center prospective observational study to compare QPlus parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing cardiac surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05290675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Quantra QPlus System
Trials testing the same drug.
- NCT05501730 — Use of the Quantra QPlus Sytem in Cardiac Surgery · completed
Other HemoSonics LLC trials
Trials by the same sponsor.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06255496 — QStat Cartridge in Obstetric Patients · completed
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT06025708 — Quantra QStat Sample Type Comparison · completed
- NCT05875987 — Evaluation of the Quantra QStat System in Obstetric Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05290675 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HemoSonics LLC
- Last refreshed: 1 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing